Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
PROSPECT-LUNG
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
- NCT06632327 ↗
- Active, not recruiting
- Alliance for Clinical Trials in Oncology
- Focused
We haven't built an HCP commentary report on PROSPECT-LUNG (nivolumab; pembrolizumab; atezolizumab in stage II-IIIB resectable non-small cell lung cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on PROSPECT-LUNG so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 7 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- Perioperative Versus Adjuvant Systemic Therapy in Patients With Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG
- Phase
- Phase 3
- Status
- Active, not recruiting
- Conditions
- Resectable Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8
- Interventions
- Surgical Procedure; Cisplatin; Carboplatin; Pemetrexed; Gemcitabine; Docetaxel; Vinorelbine; Nivolumab; Pembrolizumab; Atezolizumab; Computed Tomography; Magnetic Resonance Imaging; Positron Emission Tomography
- Arms
- Arm 1 (surgery, adjuvant therapy) · Experimental
- Arm 2 (neoadjuvant therapy, surgery, adjuvant therapy) · Experimental
- Enrollment
- 37
- Primary outcomes
- 3-year real-world event-free survival (rwEFS)
- Overall survival (OS)
- Sponsor
- Alliance for Clinical Trials in Oncology with National Cancer Institute (NCI)
- Start
- Dec 11, 2024
- Primary completion
- Apr 30, 2029 (estimated)
- Results posted
- No
- Registry record
- NCT06632327 · updated Sep 2, 2026
Publications
linked from the registry- Booth A, Hillman S, Laumann K, Zhao YQ, LeBlanc M, Chansky K, Giri S, Dill J, Johnson J, Kelley K, Martin L, Osarogiagbon RU, Morris MJ, Chiang AC, Kozono DE, Blanke CD, Galanis E, Gray JE, Stinchcombe TE, Aljumaily R, Morgensztern D, Mandrekar SJ. PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials. J Thorac Oncol. 2026 Jul;21(7):103650. doi: 10.1016/j.jtho.2026.103650. Epub 2026 Feb 24. PubMed 41747891